CULLINAN THERAPEUTICS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-5.0M | $-5.0M | $3.0K | — |
| Jun 2020 | $-6.3M | $-6.3M | $4.0K | — |
| Sep 2020 | $-9.1M | $-9.1M | $4.0K | — |
| Dec 2020 | $-9.4M | $-9.4M | $-1.0K | — |
| Mar 2021 | $-1.5M | $-1.5M | — | $3.5M |
| Jun 2021 | $-16.2M | $-16.2M | — | $4.2M |
| Sep 2021 | $-10.6M | $-10.6M | — | $4.6M |
| Dec 2021 | $-15.2M | $-15.2M | — | $12.1M |
| Mar 2022 | $-21.9M | $-21.9M | $0 | $6.6M |
| Jun 2022 | $-25.4M | $-25.4M | $0 | $8.6M |
| Sep 2022 | $-54.4M | $-54.6M | $251.0K | $5.3M |
| Dec 2022 | $-25.0M | $-25.9M | $882.0K | $7.5M |
| Mar 2023 | $-51.0M | $-51.2M | $159.0K | $7.3M |
| Jun 2023 | $-31.0M | $-31.1M | $49.0K | $7.9M |
| Sep 2023 | $-34.1M | $-34.1M | $0 | $7.7M |
| Dec 2023 | $-18.1M | $-18.1M | $0 | $7.5M |
| Mar 2024 | $-38.2M | $-38.2M | $0 | $8.2M |
| Jun 2024 | $-36.3M | $-36.3M | $0 | $10.5M |
| Sep 2024 | $-34.1M | $-34.1M | $0 | $9.4M |
| Dec 2024 | $-36.6M | $-36.6M | $0 | $9.6M |
| Mar 2025 | $-43.2M | $-43.2M | — | $9.4M |
| Jun 2025 | $-57.6M | $-57.6M | — | $9.9M |
| Sep 2025 | $-36.9M | $-36.9M | — | $9.5M |
| Dec 2025 | $-38.1M | $-38.1M | — | $7.3M |
| Mar 2026 | $-46.0M | $-46.0M | — | $7.6M |
| Jun 2026 | $-38.2M | $-38.2M | — | $8.4M |